OptionsHawk monitors insider trading activity daily and pay the greatest attention to insider buying as while selling is done for a multitude of reasons, buying is always a positive signal from management. We often notice insider activity aligning with key technical/valuation levels and can also draw conclusions from related options activity. We focus on the most intriguing insider buys which may be ones at attractive valuation, ones that are large and/or rare, or when buyers are active with shares strong and near highs.
Trading Spotlight – Weyerhaeuser (WY)
Weyerhaeuser (WY) first notable open market buy in the name this week since 2018 when a director bought 10,000 shares at $29.11. The $20.8B company trades 32.5X earnings and 3.2X sales with mid-single digit growth. Shares are down 8% for the year and rolling over...
Trading Spotlight – Quidel (QDEL)
Quidel (QDEL) with two notable buys this past week into weakness as the CEO added 5,000 shares on 8/31 at $174.99, a nearly $875,000 investment and a director bought 7,700 shares on 9/2 at $166, a more than $1.27M buy. QDEL has seen insiders active all Summer with the...
Trading Spotlight – New Relic (NEWR)
New Relic (NEWR) with a rare open market buy on 8/19 from the President/COO Michael Christenson of 9,000 shares at $56.72, a more than $500,000 investment. NEWR is down 4.5% for the year and has been a laggard in software since early 2019 when it traded up near $105....
Trading Spotlight – Pfizer (PFE)
Pfizer (PFE) with a notable insider buy on 8/6 from director Ronald Blaylock of 13,000 shares at $38.55, a more than $500,000 investment. Blaylock is the founder of Gennx360, a private equity firm, and joined the Pfizer board in 2017. PFE is consolidating in a narrow...
Trading Spotlight – Intel (INTC)
Intel (INTC) down sharply after earnings but CEO Bob Swan buying over 8,000 shares last week at $50 and follows some sizable insider buys earlier this year from directors between $58 and $65 for more than $11M. Swan has added almost 150,000 shares since December 2018...
Trading Spotlight – Herman Miller (MLHR)
Herman Miller (MLHR) with another open market buy from director Michael Volkema this past week who has now bought 50,000 shares since May between $21.45 and $22. MLHR has been hit hard due to COVID-19 with shares down near 50% for the year and more than 55% off of...
Trading Spotlight – IHS Markit (INFO)
IHS Markit (INFO) with a notable insider buy from director Robert Kelly of 7,000 shares across 6/26 and 7/1 from $72.29 to $75.88, a more than $500,000 investment. Kelly’s buys follow a $1.2M buy from director Bill Ford in March around $58.50. INFO has traded...
Trading Spotlight – Bristol Myers (BMY)
Bristol Myers (BMY) with a sizable insider buy on 6/16 from director Dinesh Paliwal of 9,174 shares at $54.50, a near $500,000 investment. This is the largest open market buy in the name since August 2019 when a director bought $491K in stock at $44.72. BMY is down...
Trading Spotlight – Cortexyme (CRTX)
Cortexyme (CRTX) small-cap bio with a big insider buy last week from director David Lamond of 49,125 shares at $43.27, a more than $2.1M investment. Shares are down 25% in 2020 but up over 65% in the last twelve months, a volatile name with ATR of around $3.75. The...
Trading Spotlight – B Riley Financial (RILY)
B Riley Financial (RILY) with some sizable insider buys this past week from Co-CEO Bryant Riley of 40,000 shares at $20.81, a more than $830,000 investment. RILY saw a lot of insiders buying stock in mid-March as well around $19.50 to $20.25. Shares are down 17% in...